ALTASCIENCES.COM: Keyword Density Checker

Total words: 3282 | 2-word phrases: 859 | 3-word phrases: 952 | 4-word phrases: 985

PAGE INFO

Title	Try to keep the title under 60 characters (87 characters) Altasciences - Contract Research Organization \| Drug Development \| Outsourcing Services
Description	Try to keep the meta description between 50 - 160 characters (187 characters) Contract research organization specialized in seamless, end-to-end, early phase drug development, we act to get your most promising compounds into and through early phase clinical trials.
Keywords	Meta keywords are not recommended anymore (187 characters) Contract research organization, Early phase CRO, Preclinical research, toxicology study, Clinical research, Phase I-IIa, Bioanalysis, Bioanalytical lab, Manufacturing and analytical, CDMO, Drug development outsourcing services
H1	H1 tag on the page (16 characters) MOVING IN UNISON

#	Keyword	Frequency	Density
1	manufacturing and analytical	4	0.42%
2	and analytical services	4	0.42%
3	to phase i	4	0.42%
4	proof of concept	3	0.32%
5	proactive drug development	3	0.32%
6	phase drug development	3	0.32%
7	moving in unison	3	0.32%
8	in vivo glp	2	0.21%
9	the drug development	2	0.21%
10	preclinical services altasciences	2	0.21%
11	preclinical evaluation studies	2	0.21%
12	altasciences preclinical services	2	0.21%
13	nonglp preclinical evaluation	2	0.21%
14	and nonglp preclinical	2	0.21%
15	glp and nonglp	2	0.21%
16	vivo glp and	2	0.21%
17	proven flexible approach	2	0.21%
18	of in vivo	2	0.21%
19	range of in	2	0.21%
20	to proof of	2	0.21%
21	clinical services altasciences	2	0.21%
22	altasciences clinical services	2	0.21%
23	with you to	2	0.21%
24	working with you	2	0.21%
25	2024 cro leadership	2	0.21%
26	a 2024 cro	2	0.21%
27	easier proactive drug	2	0.21%
28	imagine easier proactive	2	0.21%
29	altasciences offers a	2	0.21%
30	the global health	2	0.21%

#	Keyword	Frequency	Density
1	manufacturing and analytical services	4	0.41%
2	forwardthinking midsize early phase	2	0.20%
3	vivo glp and nonglp	2	0.20%
4	phase i to phase	2	0.20%
5	nonglp preclinical evaluation studies	2	0.20%
6	and nonglp preclinical evaluation	2	0.20%
7	the global health summit	2	0.20%
8	for the global health	2	0.20%
9	documentary for the global	2	0.20%
10	glp and nonglp preclinical	2	0.20%
11	preclinical to phase i	2	0.20%
12	flexible approach to early	2	0.20%
13	in vivo glp and	2	0.20%
14	of in vivo glp	2	0.20%
15	working with you to	2	0.20%
16	services working with you	2	0.20%
17	early phase drug development	2	0.20%
18	easier proactive drug development	2	0.20%
19	imagine easier proactive drug	2	0.20%
20	approach to early drug	2	0.20%
21	range of in vivo	2	0.20%
22	proven flexible approach to	2	0.20%
23	of all sizes a	2	0.20%
24	midsize early phase contract	2	0.20%
25	canada and the us	2	0.20%
26	and the us offering	2	0.20%
27	the us offering biopharmaceutical	2	0.20%
28	companies of all sizes	2	0.20%
29	to proof of concept	2	0.20%
30	thoroughly assess the safety	1	0.10%
31	with a single crocdmo	1	0.10%
32	altasciencesbioanalysis services working with	1	0.10%
33	we deliver altasciencesbioanalysisservices video	1	0.10%
34	— we deliver altasciencesbioanalysisservices	1	0.10%
35	imagine — we deliver	1	0.10%
36	to imagine — we	1	0.10%
37	altasciences you dont have	1	0.10%
38	with altasciences you dont	1	0.10%
39	journey with altasciences you	1	0.10%
40	development journey with altasciences	1	0.10%

#	URL	Whois	Check
1	https://altasciences.ca	Whois	altasciences.ca
2	https://www.linkedin.com/company/altasciences	Whois	linkedin.com
3	https://www.youtube.com/channel/UCIoBiLT0jCW0M5RJg5iba-g	Whois	youtube.com
4	https://www.reuters.com/plus/acumen/global-health/altasciences-drug-development	Whois	reuters.com
5	https://www.reuters.com/plus/acumen/global-health/altasciences-drug-development	Whois	reuters.com
6	https://www.reuters.com/plus/acumen/global-health/altasciences-drug-development	Whois	reuters.com
7	https://www.lifesciencesreview.com/magazines/February2024/CRO_Special/?digitalmagazine#page=12	Whois	lifesciencesreview.com
8	https://magazines.insightscare.com/2024/most-influential-canadian-women-leaders-in-healthcare-2024-january-2024/#page=10	Whois	insightscare.com
9	https://magazines.insightscare.com/2023/top-5-visionary-leaders-to-watch-in-healthcare-industry-2023-october2023/#page=1	Whois	insightscare.com
10	https://canr57.dayforcehcm.com/CandidatePortal/en-US/altasciences	Whois	dayforcehcm.com
11	https://www.linkedin.com/company/altasciences	Whois	linkedin.com
12	https://www.youtube.com/channel/UCIoBiLT0jCW0M5RJg5iba-g	Whois	youtube.com
13	https://www.linkedin.com/company/altasciences	Whois	linkedin.com
14	https://www.youtube.com/channel/UCIoBiLT0jCW0M5RJg5iba-g	Whois	youtube.com